Large Institutional Experience with Dose-Intensive Chemotherapy and Stem Cell Support in the Management of Sarcoma Patients

Publisher： Karger

E-ISSN： 1423-0232|73|1-2|58-64

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.1-2, 2008-03, pp. : 58-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors Determining the Actual Received Dose Intensity in a Program of Multicyclic Dose-Intensive Alternating Chemotherapy with Sequential Stem Cell Support

By  

Acta Haematologica, Vol. 105, Iss. 3, 2001-07 ,pp. : 137-142

Karger

Access to resources Recommend Favorite

Outcome of Recipients of Hematopoietic Stem Cell Transplants Who Require Intensive Care Unit Support: A Single Institution Experience

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 119-124

Karger

Access to resources Recommend Favorite

Acute Pseudo-Obstruction of the Small Intestine Following High-Dose Chemotherapy and Stem Cell Support

By  

Oncology Research and Treatment, Vol. 26, Iss. 4, 2003-09 ,pp. : 344-346

Karger

Access to resources Recommend Favorite

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Lymphoma Experience and Its Potential Relevance to Solid Tumors

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 198-206

Karger

Access to resources Recommend Favorite

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

By Cheng Yee Chung   Ueno Naoto T  

Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite